A Study of Biweekly Gemcitabine, Paclitaxel, and Avastin in Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Paclitaxel|DRUG: Gemcitabine|DRUG: Avastin
Sponsor: Barbara Ann Karmanos Cancer Institute
Collaborators: Eli Lilly and Company|Genentech, Inc.